on August 23, 2007
Published online before print August 23, 2007, doi: 10.1161/ATVBAHA.107.150748
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 16, 2007
Accepted on August 8, 2007
The PI3K/Akt Pathway Mediates the Neuroprotective Effect of Atorvastatin in Extending Thrombolytic Therapy After Embolic Stroke in the Rat
Li Zhang *;
From the Department of Neurology (L.Z., Z.G.Z., X.S.L., A.H.S. M.C.), Henry Ford Health Sciences Center, Detroit, Mich; and the Department of Physics (M.C.), Oakland University, Rochester, Minn.
* To whom correspondence should be addressed. E-mail: zhazh{at}neuro.hfh.edu.
Objective—We tested the hypothesis that the phosphatidylinositol-3 kinase (PI3K)/Akt pathway mediates the neuroprotective effect of combination therapy of atorvastatin and tissue-type plasminogen activator (tPA) in rats after stroke.
Methods and Results—Combination of atorvastatin (20 mg/kg) and tPA (10 mg/kg) significantly reduced ischemic lesion volume, whereas monotherapy with atorvastatin and tPA did not reduce the lesion volume, when the treatments were initiated 4 hours after embolic middle cerebral artery occlusion (MCAo). Western blot analysis revealed that treatment with atorvastatin alone and in combination treatment with tPA significantly increased Akt phosphorylation compared with treatment with saline and tPA alone. Inhibition of the PI3K/Akt pathway with wortmannin completely abolished the reduction of lesion volume afforded by combination of atorvastatin and tPA. Real-time RT-PCR analysis of cerebral endothelial cells isolated by laser-capture microdissection from the ischemic boundary region showed that MCAo upregulated early growth response 1 (Egr-1) and vascular endothelial growth factor (VEGF) mRNA levels and tPA monotherapy further increased Egr-1 and VEGF mRNA levels. However, combination of atorvastatin and tPA significantly suppressed Egr-1 and VEGF mRNA levels in cerebral endothelial cells.
Conclusions—Activation of Akt and downregulation of cerebral endothelial Egr-1 and VEGF gene expression by atorvastatin contribute to the neuroprotective effect of combination treatment with atorvastatin and tPA.
This article has been cited by other articles:
 |
|
 |
|
  M. Zhang, L. Lin, S.-J. Lee, L. Mo, J. Cao, E. Ifedigbo, and Y. Jin Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L945 - L953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Elewa, A. Kozak, A. B. El-Remessy, R. F. Frye, M. H. Johnson, A. Ergul, and S. C. Fagan Early Atorvastatin Reduces Hemorrhage after Acute Cerebral Ischemia in Diabetic Rats J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 532 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. An, C. Zhang, R. Polavarapu, X. Zhang, X. Zhang, and M. Yepes Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain Blood, October 1, 2008; 112(7): 2787 - 2794. [Abstract] [Full Text] [PDF]
|
|